|
The Ultraviolet Absorption of Heparin Sodium † † The expense of this investigation was defrayed in part by a grant from the Board of Trustees of the United States Pharmacopoeial Convention. ‡ ‡ We gratefully acknowledge the kind cooperation of Prof. E. Fullerton Cook, Chairman of the Committee of Revision of the United States Pharmacopoeia; Dr. H. C. Spruth of the Abbott Research Laboratories; Drs. M. F. Furter and E. G. E. Shafer of Hoffmann-LaRoche, Inc.; Dr. M. H. Kurzanga of the Upjohn Company; and Dr. Joseph Seifter of the Wyeth Institute of Applied Biochemistry. |
|
|